Association of ankylosing spondylitis with HLA-B*1403 in a West African population

Arthritis and Rheumatism

Volumn 46, Issue 11, 2002, Pages 2968-2971

  López Larrea, Carlos ^a   Mijiyawa, Moustafa ^b   González, Segundo ^c   Fernández Morera, J Luis ^a   Blanco Gelaz, Miguel A ^a   Martínez Borra, Jesús ^a   López Vázquez, Antonio ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITÉ DE LOMÉ   (Togo)

^c UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; OLIGONUCLEOTIDE;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA FINGERPRINTING; ETHNIC DIFFERENCE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS;

ADULT; ALLELES; GENETIC PREDISPOSITION TO DISEASE; HLA-B ANTIGENS; HUMANS; MALE; OLIGONUCLEOTIDE PROBES; SPONDYLITIS, ANKYLOSING; TOGO;

EID: 0036847117     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10584     Document Type: Article

References (13)

1. Khan MA. A worldwide overview: The epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog J, editors. The Spondyloarthritides. Oxford: Oxford University Press; 1998. p. 17-26.
2. Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998;41:588-95.
3. Wordsworth P. Genes in the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:845-63.
4. Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A, Tokunaga K, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients: Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995;38:1672-7.
5. Sobao Y, Tsuchiya N, Takiguchi M, Tokunaga K. Overlapping peptide-binding specificities of HLA-B27 and B39: Evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. Arthritis Rheum 1999;42:175-80.
6. Yague J, Ramos M, Vazquez J, Marina A, Albar JP, Lopez de Castro JA. The South AmerIndian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA-B27. Tissue Antigens 1999;53:227-36.
7. a promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol 2001;28:1288-93.
8. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.
9. Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP. Ankylosing spondylitis in West Africans: Evidence for non-HLA-B27 protective effect. Ann Rheum Dis 1997;56:68-70.
10. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
11. Ellis JM, Mack SJ, Leke RFG, Quakyi I, Johnson AH, Hurley CK. Diversity is demonstrated in class I HLA-A and HLA-B alleles in Cameroon, Africa: Description of HLA-A*03012, *2612, *3006 and HLA-B*1403, *4016, *4703. Tissue Antigens 2000;56:291-302.
12. López-Larrea C, Segundo G, Martinez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondyloarthropathy. Mol Med Today 1998;4:540-9.
13. DiBrino M, Parker KC, Margulies DH, Shiloach J, Turner RV, Biddison WE, et al. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J Biol Chem 1994;269:32426-34.